» Articles » PMID: 32175881

Automatic Detection of Target Engagement in Transcutaneous Cervical Vagal Nerve Stimulation for Traumatic Stress Triggers

Overview
Date 2020 Mar 17
PMID 32175881
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Transcutaneous cervical vagal nerve stimulation (tcVNS) devices are attractive alternatives to surgical implants, and can be applied for a number of conditions in ambulatory settings, including stress-related neuropsychiatric disorders. Transferring tcVNS technologies to at-home settings brings challenges associated with the assessment of therapy response. The ability to accurately detect whether tcVNS has been effectively delivered in a remote setting such as the home has never been investigated. We designed and conducted a study in which 12 human subjects received active tcVNS and 14 received sham stimulation in tandem with traumatic stress, and measured continuous cardiopulmonary signals including the electrocardiogram (ECG), photoplethysmogram (PPG), seismocardiogram (SCG), and respiratory effort (RSP). We extracted physiological parameters related to autonomic nervous system activity, and created a feature set from these parameters to: 1) detect active (vs. sham) tcVNS stimulation presence with machine learning methods, and 2) determine which sensing modalities and features provide the most salient markers of tcVNS-based changes in physiological signals. Heart rate (ECG), vasomotor activity (PPG), and pulse arrival time (ECG+PPG) provided sufficient information to determine target engagement (compared to sham) in addition to other combinations of sensors. resulting in 96% accuracy, precision, and recall with a receiver operator characteristics area of 0.96. Two commonly utilized sensing modalities (ECG and PPG) that are suitable for home use can provide useful information on therapy response for tcVNS. The methods presented herein could be deployed in wearable devices to quantify adherence for at-home use of tcVNS technologies.

Citing Articles

Noninvasive Vagal Nerve Stimulation for Opioid Use Disorder.

Douglas Bremner J, Gazi A, Lambert T, Nawar A, Harrison A, Welsh J Ann Depress Anxiety. 2023; 10(1).

PMID: 38074313 PMC: 10699253.


Evaluation of taVNS for extreme environments: an exploration study of health benefits and stress operationality.

Le Roy B, Martin-Krumm C, Gille A, Jacob S, Vigier C, Laborde S Front Neurol. 2023; 14:1286919.

PMID: 38073641 PMC: 10698866. DOI: 10.3389/fneur.2023.1286919.


Optimizing Noninvasive Vagus Nerve Stimulation for Systemic Lupus Erythematosus: Protocol for a Multicenter Randomized Controlled Trial.

Contreras I, Navarro-Otano J, Rodriguez-Pinto I, Guemes A, Alves E, Rios-Garces R JMIR Res Protoc. 2023; 12:e48387.

PMID: 37831494 PMC: 10612000. DOI: 10.2196/48387.


Transcutaneous vagal nerve stimulation modulates stress-induced plasma ghrelin levels: A double-blind, randomized, sham-controlled trial.

Moazzami K, Pearce B, Gurel N, Wittbrodt M, Levantsevych O, Huang M J Affect Disord. 2023; 342:85-90.

PMID: 37714385 PMC: 10698687. DOI: 10.1016/j.jad.2023.09.015.


Investigating Cardiorespiratory Interaction Using Ballistocardiography and Seismocardiography-A Narrative Review.

Balali P, Rabineau J, Hossein A, Tordeur C, Debeir O, van de Borne P Sensors (Basel). 2022; 22(23).

PMID: 36502267 PMC: 9737480. DOI: 10.3390/s22239565.


References
1.
Johnson R, Wilson C . A review of vagus nerve stimulation as a therapeutic intervention. J Inflamm Res. 2018; 11:203-213. PMC: 5961632. DOI: 10.2147/JIR.S163248. View

2.
Inan O, Migeotte P, Park K, Etemadi M, Tavakolian K, Casanella R . Ballistocardiography and seismocardiography: a review of recent advances. IEEE J Biomed Health Inform. 2014; 19(4):1414-27. DOI: 10.1109/JBHI.2014.2361732. View

3.
Oshinsky M, Murphy A, Hekierski Jr H, Cooper M, Simon B . Noninvasive vagus nerve stimulation as treatment for trigeminal allodynia. Pain. 2014; 155(5):1037-1042. PMC: 4025928. DOI: 10.1016/j.pain.2014.02.009. View

4.
Hamer H, Bauer S . Lessons learned from transcutaneous vagus nerve stimulation (tVNS). Epilepsy Res. 2019; 153:83-84. DOI: 10.1016/j.eplepsyres.2019.02.015. View

5.
Verkuil B, Burger A . Transcutaneous vagus nerve stimulation does not affect attention to fearful faces in high worriers. Behav Res Ther. 2018; 113:25-31. DOI: 10.1016/j.brat.2018.12.009. View